NCT07425275 Integrated Oral Care Intervention for Xerostomia in Diabetes Patients
| NCT ID | NCT07425275 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Khyber Medical University Peshawar |
| Condition | Diabetes Mellitus |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2026-02-01 |
| Primary Completion | 2026-06-25 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2026-02-01 with a primary completion date of 2026-06-25.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Diabetes patients commonly experience dry mouth also known as xerostomia which can affect eating speaking oral health and overall quality of life. This study evaluates whether simple oral care actions delivered by endocrinologists during routine diabetes clinic visits can improve dry mouth symptoms and oral health related quality of life. Endocrinologists will be trained to screen for dry mouth provide brief counseling prescribe saliva substitutes and refer patients to dental services when needed. Adult patients with diabetes and symptoms of dry mouth will be followed before and after the intervention to assess changes in xerostomia severity and oral health outcomes. The study will also explore barriers and facilitators to integrating oral health care into routine diabetes management in Pakistan.
Eligibility Criteria
Inclusion Criteria: * Presence of a single stone in the renal pelvis. * Age less than 18 years. * No congenital or acquired urinary tract abnormalities. * No pre-existing chest diseases (e.g., chronic lung disease, pleural effusion). Exclusion Criteria: * Patients with multiple kidney stones. * Calyceal stones (stones located specifically in a calyx). * Pelviureteric junction obstruction (PUJO). * Pelvic kidney (renal ectopia).
Contact & Investigator
Dr. Mahdia Babak, BDS, MPH
PRINCIPAL INVESTIGATOR
Institute of Public Health, Khyber Medical University (KMU), Peshawar, Pakistan
Frequently Asked Questions
Who can join the NCT07425275 clinical trial?
This trial is open to participants of all sexes, up to 18 Years, studying Diabetes Mellitus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07425275 currently recruiting?
Yes, NCT07425275 is actively recruiting participants. Contact the research team at mahdia.iph@kmu.edu.pk for enrollment information.
Where is the NCT07425275 trial being conducted?
This trial is being conducted at Peshawar, Pakistan.
Who is sponsoring the NCT07425275 clinical trial?
NCT07425275 is sponsored by Khyber Medical University Peshawar. The principal investigator is Dr. Mahdia Babak, BDS, MPH at Institute of Public Health, Khyber Medical University (KMU), Peshawar, Pakistan. The trial plans to enroll 80 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.